MH

Mel Hayes

Chief Operating Officer

Fulcrum Therapeutics

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Fulcrum Therapeutics
Industry
research
Employees
70.0
Seniority
C suite
Annual Revenue
80000000.0

Professional Summary

Mel Hayes serves as Chief Operating Officer at Fulcrum Therapeutics. Fulcrum Therapeutics operates in the research sector with approximately 70.0 employees. The company is headquartered in Boston, Massachusetts. Fulcrum Therapeutics generates annual revenue of 80000000.0.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • We have verified contacts for 3 executives at Fulcrum Therapeutics.
  • 3,781 executive contacts are available in Massachusetts.
  • Our database includes 201,469 c suite-level executives.

Technologies

Mimecast Hubspot WP Engine IoT Data Analytics Remote AI

Keywords

gene regulation neuromuscular diseases rare genetic diseases cardiovascular diseases biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceutical gene expression rare diseases genetically defined diseases drug targets therapeutic focus clinical trials patient-centered small molecules sickle cell disease facioscapulohumeral muscular dystrophy fshd beta-thalassemia modified gene expression therapeutic development regulatory approval biotechnology clinical development precision medicine patient advocacy drug discovery investigational therapies muscle weakness genetic counseling clinical research compassionate use orphan drugs genetic disorders patient outcomes fda approval muscle degeneration treatment access biomarker evaluation symptomatic treatment fatal diseases hemoglobinopathies biopharma pipeline patient engagement safety & efficacy disease biology patient-driven development clinical innovations pathophysiology community outreach healthcare advancements scientific leadership corporate governance investor relations clinical-stage biopharmaceutical small molecule therapies gene mis-expression disease-modifying therapies patient-centered approach proprietary technology genomic screening losmapimod ftx-6058 facioscapulohumeral muscular dystrophy (fshd) sickle cell disease (scd) neuromuscular disorders hematologic disorders patient-derived models biomarker-guided discovery collaboration with sanofi innovative research high unmet medical need healthcare providers genetic counselors pharmaceutical partnerships rare disease community fulcrumseek™ genetic medicine therapeutic pipeline health wellness & fitness hospital & health care

Related Executives

AS
Alex Sapir Chief Executive Officer at Fulcrum Therapeutics
JJ
Jeff Jacobs Chief Scientific Officer and Head of Technical Operations at Fulcrum Therapeutics
SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands

Frequently Asked Questions

How can I contact Mel Hayes?

Mel Hayes's verified email address is available on MessageCEO. They currently work at Fulcrum Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Mel Hayes lead?

Mel Hayes is Chief Operating Officer at Fulcrum Therapeutics, a company in the research sector with 70.0 employees. The company is based in Boston, Massachusetts.

What industry is Mel Hayes in?

Mel Hayes works in the research industry as Chief Operating Officer at Fulcrum Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Mel Hayes's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mel Hayes's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 7, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans